Baixar PDF

Outros usuários também visualizaram estes artigos

Brazilian chronic myeloid leukemia working group recommendations for discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia in clinical practice Carla Boquimpani; Fernanda Salles Seguro; Gustavo Henrique Romani Magalhães; Ingrid Luise Soares Pinto; Israel Bendit; Jaisson André Pagnoncelli Bortolini; Katia Borgia Barbosa Pagnano; Renato Centrone; Vaneuza Funke;
Hematol Transfus Cell Ther. 2022;44:402-9
Epidemiological characterization of chronic myeloid leukaemia patients at an oncologic centre: A retrospective observational study Ana Maria Meireles; Rita Calisto; Maria José Bento; Pedro Martinho Gouveia; Susana Bizarro; Manuel Teixeira; Cláudia Moreira; Ana Espírito Santo; Mário Mariz;
10.1016/j.htct.2025.103935
Recommendations for the management of cardiovascular risk in patients with chronic myeloid leukemia on tyrosine kinase inhibitors: risk assessment, stratification, treatment and monitoring Fernanda Salles Seguro; Carolina Maria Pinto Domingues Carvalho Silva; Carla Maria Boquimpani de Moura; Monika Conchon; Laura Fogliatto; Vaneuza Araujo Moreira Funke; André Abdo; Ariane Vieira Scarlatelli Macedo; Marilia Harumi Higushi dos Santos; José Francisco Kerr Saraiva;
Hematol Transfus Cell Ther. 2021;43:191-200